Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
859.6500 -20.60 (-2.34%)
NSE Apr 25, 2025 15:31 PM
Volume: 1.1M
 

859.65
-2.34%
KRChoksey
ZYDUSLIF reported 9.1% y-o-y (-15.0% Q-o-Q) rise in revenue to Rs. 43,688 Mn in Q2FY24., which is 6.7% below the estimates of Rs. 46,837 Mn. The growth was lower than anticipated due to lower than expected growth in the US, India, and Consumer Wellness segments.; partially offset by better than anticipated growth in APIs and Emerging Market formulation segments.
Zydus Lifesciences L.. has an average target of 1052.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended